LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling
2021 · Toxicology Letters · 24 citations
https://doi.org/10.1016/j.toxlet.2021.05.006
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
623
Citations
14
h-index
18
i10-index
Xiaojiang Li is an academic researcher from Changchun University of Chinese Medicine. The author has contributed to research in topics: Legal and Regulatory Analysis & Linguistic, Cultural, and Literary Studies & Military Technology and Strategies. The author has an h-index of 14, co-authored 32 publications.
ORCID: 0000-0002-8487-0315https://doi.org/10.1016/j.toxlet.2021.05.006
https://doi.org/10.1038/s41598-023-32217-z
https://doi.org/10.6084/m9.figshare.11316212
Click to start Chat